Kimberlee Drapkin

Director at Climb Bio.

Earliest Form D on file: May 2026

Filed May 4, 2026

Climb Bio

B-cell depleting antibodies for autoimmune disease

Biotech, Wellesley Hills MA

Named, Director.

$110.1M

sold of $110.1M offered

Network

At Climb Bio

8 people

Aoife Brennan
Executive Officer, Director, signed as President and Chief Executive Officer
Alexander (Bo) Combo
Director
Andrew Levin
Director
Douglas Williams
Director
Judith Dunn
Director
Perrin Wilson
Executive Officer

2 more at Climb Bio